Sandra Iannotti, MD
Orthopedic Surgery · Smithtown, NYNPI 1235151572
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Arthrex at 48.8% of the total. Reporting peaked in 2022 at $3,497 and has fallen 96.7% since, to $115 in 2025.
Across 43 payments — averaging $126.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Gotham Surgical Solutions & Devices, Inc.$2K
- Polaris Technology Solutions LLC$631
- Ferring Pharmaceuticals Inc.$223
- Merck$99
- Pfizer$79
- plus $77 from 3 others
What the payments were for
- Speaking & faculty fees$791%
- Travel & lodging$1,86934%
- Food & beverage$1,07420%
- Education$2,40044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $2,645 |
| Gotham Surgical Solutions & Devices, Inc. | 5 | $1,668 |
| Polaris Technology Solutions LLC | 3 | $631 |
| Ferring Pharmaceuticals Inc. | 10 | $223 |
| Merck | 1 | $99 |
| Pfizer | 1 | $79 |
| Pacira Pharmaceuticals Incorporated | 1 | $30 |
| Johnson & Johnson | 1 | $29 |
| Amgen | 1 | $18 |
How this compares
$5,422 in reported general payments places this provider in the 75th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 26 | $217 |
| Cyclobenzaprine Hcl | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Smithtown
- Baron LonnerNew York$2.1M
- Jan KoenigRockville Centre$1.4M
- Lon WeinerNew York$622K
- Andrew CappuccinoLockport$581K
- Douglas PadgettUniondale$407K
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
- Jason McKeanBrooklyn$61K
- Daniel ZuchelliBrooklyn$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.